Ge healthcare expands on-device triage capabilities of critical care suite with fda clearance of algorithm for pneumothorax detection, notification, triage and diagnosis

Chicago--(business wire)--today ge healthcare (nasdaq: gehc) announced an industry-first us fda 510k clearance of critical care suite 2.1 featuring a pneumothorax (ptx) algorithm for the detection, notification, triage and diagnosis of ptx. the updated ptx algorithm expands critical care suite's on-device triage capabilities by providing immediate notification of the presence or absence of pneumothorax, as well as an overlay display both on-device and in pacs to assist with ptx localization. x-.
GEHC Ratings Summary
GEHC Quant Ranking